4348 Organometallics, Vol. 21, No. 21, 2002
Canovese et al.
tetraester HO-[Py]3-(CO2Et)4 5 (944 mg, 1.58 mmol), anhy-
drous K2CO3 (260 mg, 1.88 mmol), and 4-benzyloxy-2,6-bis(4-
chloromethylphenylthiomethyl)pyridine, 3 (395 mg, 0.75 mmol),
in dry DMF (20 mL). Purification by flash chromatography
eluting with 3% MeOH in CH2Cl2 gave 8 as a glassy solid (1.05
g, 85%). 1H NMR (CDCl3): δ 1.45 (t, 24H, J ) 7.1 Hz, CH2CH3),
4.23 (s, 4H, CH2S), 4.47 (q, 16H, J ) 7.1 Hz, CH2CH3), 5.00
(s, 2H, PhCH2O), 5.07 (s, 4H, CH2Opyr), 5.29 (s, 8H, pyrCH2-
Opyr), 6.88 (s, 2H, pyr-H3,5), 7.03 (s, 4H, pyr-H3,5), 7.32 (m 13
H, Ph-H), 7.89 (s, 8H, pyr-H3,5). 13C NMR (CDCl3): δ 13.9 (CH3-
CH2), 39.6 (CH2S), 62.2 (CH3CH2), 69.6 and 70.5 (CH2O), 107.4,
107.9, and 114.3 (pyr-C3,5), 127.3, 128.0, 128.1, 128.4, 128.8,
132.6, 135.2, and 136.7 (Ph-C), 150.1, 156.4, and 158.4 (pyr-
([SNS(1)PdC3H6]+). Anal. Calcd for C54H55F3N3O14PdS3C: C,
52.75; H, 4.51; N, 3.42. Found: C, 52.70; H, 4.68; N, 3.26.
[P d (η3-C3H5)SNS(2)]SO3CF 3. The title compound was
obtained as the [Pd(η3-C3H5)(SNS)]SO3CF3 complex using SNS-
1
(2) as ligand. Yield: 59% (whitish powder). H NMR (CDCl3):
δ 1.45 (t, 12H, CH2CH3, J ) 7.1 Hz), 3.97 (bs, 4H, all-CH2),
4.45 (q, 8H, J ) 7.1 Hz, CH2CH3,), 4.49 (s, 4H, CH2S), 5.07 (s,
2H, PhCH2O), 5.10 (s, 4H, CH2Opyr), 5.30 (s, 8H, pyrCH2-
Opyr), 5.74 (bq, 1H, all-CH), 7.02 (bs, 6H, pyr-H3,5), 7.24-7.47
(m, 13H, Ph-H), 7.89 (s, 8H, pyr-H3,5). 13C NMR (CDCl3): δ
14.6 (CH3CH2), 44.9 (CH2S), 62.9 (CH3CH2), 66.1 (all-CH2), 69.9
and 71.2 (CH2O), 108.0, 110.6, and 115.0 (pyr-C3,5), 116.8 (all-
CH), 128.1, 128.9, 129.0, 129.2, 130.9, 135.1, and 135.5 (Ph-
C), 150.8, 157.3, and 159.8 (pyr-C2,6), 164.9 (CdO), 166.6, 166.9,
and 167.3 (pyr-C4). MALDI-MS: m/z 1758 ([SNS(2)Pd]+), 1799
([SNS(2)PdC3H6]+). IR (cm-1): 1742 and 1724 (CdO). Anal.
Calcd for C90H91F3N7O26PdS3: C, 55.54; H, 4.71; N, 5.04.
Found: C, 55.66; H, 4.58; N, 4.79
C
2,6), 164.2 (CdO), 165.8, 165.9, and 166.3 (pyr-C4). IR (cm-1):
1745 and 1720 (CdO). MALDI-MS: m/z 1673 ([M + Na]+).
Anal. Calcd for C86H85N7O23S2: C, 62.65; H, 5.20; N, 5.95.
Found: C, 61.31; H, 4.99; N, 5.79.
SNS(3), 9. Compound 9 was prepared as described for 7
starting from the dendron (CO2Et)8-[Py]7-OH 6 (1.2 g, 0.91
mmol), anhydrous K2CO3 (0.133 g, 0.96 mmol), 18-crown-6 (24
mg, 0.09 mmol), and 4-benzyloxy-2,6-bis(4-chloromethylphe-
nylthiomethyl)pyridine, 3 (0.226 g, 0.43 mmol), in dry DMF
(20 mL) at 50 °C for 48 h. The crude product was purified by
flash chromatography eluting with 3% MeOH in CH2Cl2 and
finally recrystallized from CH2Cl2/EtOH (1:2, 15 mL) to give
9 as an amorphous white solid (1.101 g, 82%). 1H NMR
(CDCl3): δ 1.44 (t, 48H, J ) 7.1 Hz, CH2CH3), 4.21 (s, 4H,
CH2S), 4.46 (q, 32H, J ) 7.1 Hz, CH2CH3), 4.99 (s, 2H,
PhCH2O), 5.06 (s, 4H, CH2Opyr), 5.21 (s, 8H, pyrCH2Opyr),
5.32 (s, 16H, pyrCH2Opyr), 6.86 (s, 2H, pyr-H3,5), 7.00 (s, 4H,
pyr-H3,5), 7.09 (s, 8H, pyr-H3,5), 7.31 (m 13 H, Ph-H), and 7.90
(s, 16H, pyr-H3,5). 13C NMR (CDCl3): δ 13.9 (CH3CH2), 39.7
(CH2S), 62.2 (CH3CH2), 69.6, 70.2, and 70.5 (CH2O), 107.2,
107.3, 107.9, and 114.3 (pyr-C3,5), 127.3, 128.0, 128.4, 128.6,
132.6, 135.2, and 136.8 (Ph-C), 150.1, 156.7, 156.8, and 158.3
(pyr-C2,6), 164.2 (CdO), 165.8, 165.9, 166.0, and 166.3 (pyr-
C4). IR (cm-1): 1745 and 1720 (CdO). MALDI-MS: m/z 3106
([M + Na]+). Anal. Calcd for C158H157N15O47S2‚H2O‚CHCl3: C,
59.32; H, 5.01; N, 6.53. Found: C, 60.57; H, 4.76; N, 6.55.
Syn th esis of P a lla d iu m (II) Com p lexes. [P d (η3-C3H5)-
SNS(0)]SO3CF 3. To a solution of 87.1 mg (0.238 mmol) of [Pd2-
(µ-Cl)2(η3-C3H5)2] in freshly distilled CH2Cl2 (10 mL) was added
123.3 mg (0.479 mmol) of AgSO3CF3 under inert atmosphere
(N2). The solution, magnetically stirred, was reacted in the
dark for 4 h. To the filtered solution was added 161.8 mg (0.5
mmol) of 2,6-bis(phenylthiomethyl)pyridine (SNS) ligand. The
resulting mixture was stirred for 30 min and finally treated
with activated charcoal for 10 min and filtered on Celite filter.
Addition of Et2O to the cooled (ice bath) and concentrated
solution yields 235.6 mg (0.38 mmol 76%) of the title complex
[P d (η3-C3H5)SNS(3)]SO3CF 3. The title compound was
obtained as the [Pd(η3-C3H5)(SNS)]SO3CF3 complex using SNS-
1
(3) as ligand. Yield: 86% (whitish powder). H NMR (CDCl3):
δ 1.43 (t, 48H, J ) 7.1 Hz, CH2CH3), 4.09 (bd, 2H, all-CH2),
4.43 (q, 32H, J ) 7.1 Hz, CH2CH3), 4.59 (bs, 4H, CH2S), 5.09
(bs, 6H, CH2Opyr and PhCH2O), 5.20 (s, 8H, pyrCH2Opyr) 5.31
(s, 16H, pyrCH2Opyr), 7.01 (s, 6H, pyr-H3,5), 7.09 (s, 8H, pyr-
H
3,5) 7.31-7.52 (m 13 H, Ph-H), and 7.89 (s, 16H, pyr-H3,5).
13C NMR (CDCl3): δ 13.9 (CH3CH2), 46.0 (CH2S), 62.2
(CH3CH2), 66.9 (all-CH2), 69.0, 70.2, 70.5, and 70.9 (CH2O),
107.1, 107.4, 110.6, and 114.3 (pyr-C3,5), 117.5 (all-CH), 127.5,
128.0, 128.5, 128.6, 131.0, 131.4, 134.0, and 136.1 (Ph-C),
150.1, 156.6, 156.9, and 159.4 (pyr-C2,6), 164.2 (CdO), 165.9,
166.0, and 167.0 (pyr-C4). IR (cm-1): 1743 and 1721 (CdO).
MALDI-MS: m/z 3190 ([SNS(3)Pd]+), 3231 ([SNS(3)PdC3H6]+).
Anal. Calcd for C162H163F3N15O50PdS3: C, 57.57; H, 4.86; N,
6.22. Found: C, 57.44; H, 4.80; N, 6.21.
[P d (η3-1,1-(CH 3)2C3H 3)SNS(0)]SO3CF 3. The title com-
pound was obtained following the usual synthetic scheme
using [Pd2(µ-Cl)2(η3-1,1-(CH3)2C3H3)2] as starting material and
SNS(0) as ligand. Yield: 73% (whitish powder). 1H NMR
(CDCl3): δ 1.51 (s, 3H, all-CH3 anti), 1.82 (s, 3H, all-CH3 syn),
4.18 (d, 2H, J ) 10.4 Hz, all-CH2), 5.58 (s, 4H, CH2S), 5.67 (t,
1H, J ) 10.4 Hz, all-CH), 7.16-7.45 (m, 2H, pyr-H3,5 and Ph-
H), 7.63 (t, 1H, J ) 7.7 Hz, pyr-H4). 13C NMR (CDCl3): δ 23.3
(all-CH3 anti), 29.3 (all-CH3 syn), 46.8 (CH2S), 62.5 (all-CH2), 99.3
(all-C(CH3)2), 112.4 (all-CH), 124.7 (pyr-C3,5), 129.7, 130.2,
131.1, and 132.2 (Ph-C), 140.3 (pyr-C4), 159.5 (pyr-C2,6). Anal.
Calcd for
C25H27F3NO3PdS3: C, 46.26; H, 4.19; N, 2.16.
Found: C, 46.06; H, 4.02; N, 2.11.
[P d (η3-1,1-(CH 3)2C3H 3)SNS(1)]SO3CF 3. The title com-
pound was obtained as the [Pd(η3-1,1-(CH3)2C3H3)SNS(0)]SO3-
CF3 complex using SNS(1) as ligand. Yield: 73% (whitish
powder). 1H NMR (CDCl3): δ 1.44 (t, 12H, J ) 7.1 Hz,
CH2CH3), 1.48 (bs, 3H, all-CH3 anti), 1.80 (s, 3H, all-CH3 syn),
4.11 (d, 2H, J ) 10.5 Hz, all-CH2), 4.45 (q, 8H, J ) 7.1 Hz,
CH2CH3), 4.52 (s, 4H, CH2S), 5.10 (s, 2H, PhCH2O), 5.20 (s,
4H, CH2Opyr), 5.56 (t, 1H, all-CH, J ) 10.5 Hz), 6.97 (s, 2H,
1
as a whitish precipitate. H NMR (CDCl3): δ 4.20 (d, 4H, J )
9.8 Hz, all-CH2), 4.62 (s, 4H, CH2S), 5.98 (q, 1H, J ) 9.8 Hz,
all-CH), 7.19-7.43 (m, 12H, pyr-H3,5 and Ph-H), 7.66 (t, 1H, J
) 7.8 Hz, pyr-H4). 13C NMR (CDCl3): δ 47.1 (CH2S), 67.4 (all-
CH2), 118.8 (all-CH), 124.5 (pyr-C3,5), 129.6, 130.1, 131.3, and
132.2 (Ph-C), 140.4 (pyr-C4), 159.4 (pyr-C2,6). Anal. Calcd for
pyr-H3,5), 7.31-7.58 (m, 13H, Ph-H), 7.83 (s, 4H, pyr-H3,5). 13
C
C
23H23F3NO3PdS3: C, 44.48; H, 3.73; N, 2.26. Found: C, 44.32;
H, 3.98; N, 2.51.
NMR (CDCl3): δ 14.6 (CH3CH2), 23.2 (all-CH3 anti), 29.3 (all-
CH3 syn), 46.7 (CH2S), 62.5 (all-CH2), 62.9 (CH3CH2), 70.1 and
71.6 (CH2O), 99.8 (all-C(CH3)2), 111.9 (all-CH), 111.5 and 114.9
(pyr-C3,5), 128.2, 129.0, 129.1, 129.2, 132.0, 132.4, 134.9, and
136.6 (Ph-C), 150.8 and 160.6 (pyr-C2,6), 165.0 (CdO), 166.7
and 167.5 (pyr-C4). IR (cm-1): 1744 and 1720 (CdO). MALDI-
MS: m/z 1041 ([SNS(1)Pd]+), 1110 ([SNS(1)PdC5H10]+). Anal.
Calcd for C56H58F3N3O14PdS3: C, 53.52; H, 4.65; N, 3.34.
Found: C, 53.45; H, 4.71; N, 3.36
[P d (η3-C3H5)SNS(1)]SO3CF 3. The title compound was
obtained as the [Pd(η3-C3H5)(SNS)]SO3CF3 complex using SNS-
1
(1) as ligand. Yield: 75% (whitish powder). H NMR (CDCl3):
δ 1.45 (t, 12H, J ) 7.1 Hz, CH2CH3), 3.99 (bs, 4H, all-CH2),
4.45 (q, 8H, J ) 7.1 Hz, CH2CH3), 4.56 (s, 4H, CH2S), 5.08 (s,
2H, PhCH2O), 5.18 (s, 4H, CH2Opyr), 5.79 (bq, 1H, all-CH, J
) 9.9 Hz), 6.97 (s, 2H, pyr-H3,5), 7.32-7.51 (m, 13H, Ph-H),
7.82 (s, 4H, pyr-H3,5). 13C NMR (CDCl3): δ 14.6 (CH3CH2), 45.3
(CH2S), 62.9 (CH3CH2), 66.3 (all-CH2), 70.3 and 71.4 (CH2O),
110.9 and 114.9 (pyr-C3,5), 117.2 (all-CH), 128.1, 129.1, 129.2
131.7, 133.3, 135.0, and 135.7 (Ph-C), 150.7 and 160.0 (pyr-
[P d (η3-1,1-(CH 3)2C3H 3)SNS(2)]SO3CF 3. The title com-
pound was obtained as the [Pd(η3-1,1-(CH3)2C3H3)SNS(0)]SO3-
CF3 complex using SNS(2) as ligand. Yield: 73% (whitish
1
C
2,6), 165.0 (CdO), 166.7 and 167.4 (pyr-C4). IR (cm-1): 1744
and 1720 (CdO). MALDI-MS: m/z 1042 ([SNS(1)Pd]+), 1082
powder). H NMR (CDCl3): δ 1.36 (s, 3H, all-CH3 anti), 1.44 (t,
24H, J ) 7.1 Hz, CH2CH3), 1.66 (s, 3H, all-CH3 syn), 3.86 (bs,